Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Pharmacia & Upjohn prepares stereoisomers of FCE-28260

March 24, 1997

BBI Pharmaceuticals to fund phase I trial with soybean extract in BPH

March 14, 1997

Positive phase III results for GelTex's RenaGel

March 12, 1997

Roussel Uclaf reports agents for BPH

March 11, 1997

New selective alpha1a/A-antagonist from Abbott

March 10, 1997

Pharmacokinetic-pharmacodynamic interactions between terazosin and finasteride

March 3, 1997

Agents for urinary incontinence from Nippon Shinyaku

Feb. 28, 1997

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Agents for BPH disclosed by Merck & Co.

Feb. 19, 1997

Natural 5alpha-reductase inhibitors discovered at Taisho

Feb. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...